NCT01220245
Completed
Not Applicable
Heparin-bonded Endoluminal Versus Surgical Femoropopliteal Bypass; a Multicentre Randomized Controlled Trial
Rijnstate Hospital6 sites in 1 country129 target enrollmentOctober 2010
ConditionsCardiovascular Diseases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Rijnstate Hospital
- Enrollment
- 129
- Locations
- 6
- Primary Endpoint
- Primary (and -assisted) patency
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
In this multicentre Randomized Clinical Trial, the heparin-bonded endoluminal bypass will be compared to the surgical venous femoro-popliteal bypass, based on the non-inferiority principle for the patency. Besides equal patency, an improved quality of life is expected. Recruitment will take the first two years and patients will be followed during five years. Patients with an indication for surgical bypass, classified category 3-6 with a >50% stenosis or occlusion of the SFA over >/=10 cm in length will be included. At least one crural artery should be patent without significant lesions.
Investigators
Michel Reijnen
Principal Investigator
Rijnstate Hospital
Eligibility Criteria
Inclusion Criteria
- •Age over 18 years
- •Informed consent
- •Novo stenosis, restenosis \>50% or occlusion of the native SFA, all \> 10cm in length
- •Patent popliteal artery at the upper margin of the patella to the trifurcation
- •Diameter native SFA and popliteal artery are 5.0-7.5 mm
- •Indication for surgical bypass
- •Distal run-off at least one crural artery without significant stenosis
- •Ankle-brachial index (ABI) at rest \< 0.8 in the study limb prior to procedure
Exclusion Criteria
- •Patient unsuitable for administration of contrast agent
- •Pregnancy
- •Dementia or altered mental status that would prohibit giving conscious informed consent
- •Need for adjunctive major surgical or vascular procedures within one month
- •Untreated flow-limiting aortoiliac occlusive disease
- •Perioperative unsuccessful ipsilateral percutaneous vascular procedure to treat inflow disease just prior to enrollment
- •Femoral or popliteal aneurysm of target vessel
- •Non-arthrotic disease resulting in occlusion (e.g. embolism, Buerger's disease, vasculitis)
- •Severe medical comorbidities (untreated CAD/CHF, severe COPD, metastatic malignancies, dementia etc.) or other medical condition that would preclude compliance with study protocol
- •Major distal amputation (above the transmetatarsal) in the study limb
Outcomes
Primary Outcomes
Primary (and -assisted) patency
Time Frame: 5 years
Quality of life
Time Frame: 5 years
Secondary Outcomes
- Re-intervention(5 years)
- Secondary patency(5 years)
- Clinical improvement(5 years)
- Target lesion revascularisation(5 years)
- Complications(5 years)
Study Sites (6)
Loading locations...
Similar Trials
Terminated
Not Applicable
Prime Time for Superficial Femoral Artery (SFA) - The SFA StudyPeripheral Vascular DiseaseNCT00902317Arizona Heart Institute130
Terminated
Not Applicable
Bypass or Thurpass for Superficial Femoral Artery Occlusion? Scandinavian Thurpass StudyFemoral Artery OcclusionNCT00810134University of Helsinki44
Completed
Not Applicable
Ruptured Aorta-iliac Aneurysms: Endo vs. SurgeryRuptured Aorta-iliac AneurysmsNCT00577616Assistance Publique - Hôpitaux de Paris107
Not yet recruiting
Not Applicable
The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal LesionsPeripheral Arterial DiseaseNCT06124755RenJi Hospital60
Completed
Not Applicable
Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut WorkstationPeripheral Arterial DiseaseNCT04709991Therenva200